Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Fastighets AB Trianon in connection with its listing on Nasdaq Stockholm
Mandate

Vinge advises Fastighets AB Trianon in connection with its listing on Nasdaq Stockholm

December 18, 2020 Capital Markets and Public M&A M&A

Vinge has advised Fastighets AB Trianon (publ) in connection with its list change from Nasdaq First North Premier Growth Market to Nasdaq Stockholm’s main market.

The prospectus was published on 15 December 2020 and the trading on Nasdaq Stockholm commenced on 17 December 2020.

Vinge’s team primarily consisted of Christian Lindhé, Erik Sjöman, Astrid Isberg and Sophia Reutercrona (Capital markets and public M&A) as well as Anna Edström and Philip Åberg (M&A).

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025